Brief: Vicore Pharma Q2 Operating Loss Widens To SEK 24.8 Mln
23/08/2019 07:08
Aug 23 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* INTERIM REPORT APRIL-JUNE 2019
* Q2 OPERATING LOSS WAS -24.8 MSEK (-9.6)
Source text for Eikon: ID:nWkrbKYXnP
Further company coverage: VICOR.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2